$137.74
1.41%
Nasdaq, Sep 02, 10:00 pm CET

Masimo Corporation Stock price

$137.74
-23.53 14.59% 1M
-52.89 27.74% 6M
-27.56 16.67% YTD
+20.22 17.21% 1Y
-6.53 4.53% 3Y
-94.72 40.75% 5Y
+97.58 242.98% 10Y
+119.62 660.22% 20Y
Nasdaq, Closing price Tue, Sep 02 2025
-1.97 1.41%

Key metrics

Basic
Market capitalization
$7.6b
Enterprise Value
$8.1b
Net debt
$464.1m
Cash
$149.6m
Shares outstanding
54.3m
Valuation (TTM | estimate)
P/E
negative | 25.7
P/S
4.1 | 4.9
EV/Sales
4.4 | 5.2
EV/FCF
54.3
P/B
7.3
Financial Health
Equity Ratio
40.1%
Return on Equity
-29.0%
ROCE
6.6%
ROIC
7.1%
Debt/Equity
0.6
Financials (TTM | estimate)
Revenue
$1.8b | $1.6b
EBITDA
$190.7m | $484.1m
EBIT
$118.9m | $405.1m
Net Income
$-459.2m | $295.2m
Free Cash Flow
$148.4m
Growth (TTM | estimate)
Revenue
-8.4% | -26.0%
EBITDA
-26.2% | 238.8%
EBIT
-27.1% | 915.3%
Net Income
-678.3% | 196.8%
Free Cash Flow
33.6%
Margin (TTM | estimate)
Gross
52.8%
EBITDA
10.3% | 31.2%
EBIT
6.4%
Net
-24.9% | 19.0%
Free Cash Flow
8.0%
More
EPS
$-8.4
FCF per Share
$2.7
Short interest
11.0%
Employees
4k
Rev per Employee
$580.0k
Show more

Is Masimo Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Masimo Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Masimo Corporation forecast:

12x Buy
80%
3x Hold
20%

Analyst Opinions

15 Analysts have issued a Masimo Corporation forecast:

Buy
80%
Hold
20%

Financial data from Masimo Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
1,848 1,848
8% 8%
100%
- Direct Costs 873 873
15% 15%
47%
975 975
2% 2%
53%
- Selling and Administrative Expenses 667 667
3% 3%
36%
- Research and Development Expense 190 190
5% 5%
10%
191 191
26% 26%
10%
- Depreciation and Amortization 72 72
25% 25%
4%
EBIT (Operating Income) EBIT 119 119
27% 27%
6%
Net Profit -459 -459
678% 678%
-25%

In millions USD.

Don't miss a Thing! We will send you all news about Masimo Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Masimo Corporation Stock News

Neutral
Business Wire
6 days ago
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the Wells Fargo Healthcare Conference on Thursday, Sept 4, 2025 at 1:30 p.m. Eastern time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation. About Masimo Masimo (NASDA...
Negative
Reuters
13 days ago
Medical monitoring technology company Masimo sued U.S. Customs and Border Protection on Wednesday over a decision by the agency that allowed Apple to import Apple Watches with blood-oxygen reading technology during a patent dispute between the companies.
Neutral
Business Wire
15 days ago
IRVINE, Calif.--(BUSINESS WIRE)-- #Masimo--Masimo O3®'s delta hemoglobin parameters have received FDA clearance for cerebral and somatic applications and all patient populations.
More Masimo Corporation News

Company Profile

Masimo Corp. is a medical technology company, which develops, manufactures and markets non invasive patient monitoring technologies, medical devices and sensors. Its products include continuous monitors, patient-worn monitors, hospital automation connectivity, capnography & gas, data download & analytics and sensors & accessories. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.

Head office United States
CEO Catherine Szyman
Employees 3,600
Founded 1989
Website www.masimo.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today